[Surveillance of Healthcare Associated Infections, Bacterial Resistance and Antibiotic Consumption in High-complexity Hospitals in Colombia, 2011]
Overview
Authors
Affiliations
Introduction: Preventing healthcare associated infections, especially for resistant microorganisms, is a priority. In Colombia, the surveillance of such events was started through a national pilot study.
Objective: To describe the epidemiology of device-associated infections, bacterial resistance and antibiotic consumption patterns in institutions with intensive care units (ICU), 2011.
Materials And Methods: Descriptive observational study in 10 health institutions from three Colombian provinces: Antioquia, Valle del Cauca, and Bogotá. Surveillance protocols were designed and implemented by trained health professionals in each hospital. A web tool was designed for data reporting and analysis. Infection rates, device-use percentages and antibiotics defined daily dose (DDD) were calculated. Bacterial resistance phenotypes and profiles were reported and analyzed using Whonet 5.6.
Results: The most common event was bloodstream infection (rate > 4.8/1000 catheter-days) followed by ventilator-associated pneumonia (VAP) and catheter-related urinary tract infection, showing a wide variability among institutions. A high consumption of meropenem in the ICU (DDD 22.5/100 beds-day) was observed, as well as a high carbapenem resistance (> 11.6%) and a high frequency of third generation cephalosporins resistance (> 25.6%) in Enterobacteriaceae in ICUs and hospitalization wards. The percentage of methicillin-resistant Staphylococcus aureus was higher in hospitalization wards (34.3%).
Conclusions: This is the first experience in measuring these events in Colombia. It is necessary to implement a national surveillance system aimed at guiding governmental and institutional actions oriented to infection prevention and control, to resistance management and to the promotion of antibiotics rational use, along with a follow-up and monitoring process.
Lopez L, Luque M, Rivero M, Abdala M, Carranza P, Luna B Vet Res Commun. 2023; 47(3):1687-1695.
PMID: 37100969 DOI: 10.1007/s11259-023-10124-y.
Impact of Antibiotics as Waste, Physical, Chemical, and Enzymatical Degradation: Use of Laccases.
Mora-Gamboa M, Rincon-Gamboa S, Ardila-Leal L, Poutou-Pinales R, Pedroza-Rodriguez A, Quevedo-Hidalgo B Molecules. 2022; 27(14).
PMID: 35889311 PMC: 9319608. DOI: 10.3390/molecules27144436.
The Role of Uniform Meropenem Usage in Clone Replacement.
Balazs B, Toth Z, Nagy F, Kovacs R, Toth H, Nagy J Antibiotics (Basel). 2021; 10(2).
PMID: 33572723 PMC: 7911629. DOI: 10.3390/antibiotics10020127.
Higuita-Gutierrez L, Villamil G, Quiceno J BMC Public Health. 2020; 20(1):1861.
PMID: 33276767 PMC: 7718705. DOI: 10.1186/s12889-020-09971-0.
Vanegas Munera J, Ocampo Rios A, Montoya Urrego D, Quiceno J Braz J Infect Dis. 2017; 21(5):493-499.
PMID: 28432878 PMC: 9425527. DOI: 10.1016/j.bjid.2017.03.010.